Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension

Clinical Physiology and Functional Imaging

Volumn 29, Issue 3, 2009, Pages 170-176

  Pronko, T P ^a   Zinchuk, V V ^a  

^a GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

Blood; Endothelium; Hhaemoglobin oxygen affinity; Nitric oxide

Indexed keywords

ATENOLOL; ENALAPRIL; NEBIVOLOL; NITRIC OXIDE;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGENATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXYGEN AFFINITY; OXYGEN TRANSPORT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARGININE; BENZOPYRANS; DRUG THERAPY, COMBINATION; ENALAPRIL; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; OXYGEN; OXYHEMOGLOBINS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 63349112399     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2008.00852.x     Document Type: Article

References (39)

1. Angelo M, Singel DJ, Stamler JS. An S-nitrosothiol synthase function of hemoglobin that utilizes nitrite as a substrate. PNAS (2006); 103: 8366-8371.
2. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens (2002); 9: 1793-1797.
3. Cannon R. Role of nitric oxide in cardiovascular disease: Focus on the endothelium. Clin Chem (1998); 44: 1809-1819.
4. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992); 340: 1111-1115.
5. Cockcroft J. Nebivolol: A review. Expert Opin Pharmacother (2004); 4: 893-899.
6. Cockroft JR, Chowienczyk PJ, Brett SE. Nebivolol vasodilates human foream vasculature: Evidence for an L-arginine/No-dependent mechanism. Amer Soc Pharmacol Exp Ther (1995); 274: 1067-1071.
7. Dawes M, Brett S, Chowiencyzk P. The vasodilatator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol (1999); 48: 460-463.
8. Erzen B, Gradisek P, Poredos P, Sabovic M. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries. Angiology (2006); 57: 187-192.
9. European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens (2003); 21: 1011-1053.
10. Gladwin MT, Shelhamer JH, Schechter AN. Role of circulating nitrite and S-nitrosohenoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci (2000); 97: 11482-11487.
11. Gladwine MT, Lancaster JR, Freeman BA, Schechter AN. Nitric oxides reactions with hemoglobin: A view through The SNO-storm. Nat Med (2003); 9: 496-500.
12. Hermann M, Flammer A, Lüscher T. Nitric oxide in hypertension. J Clin Hypertens (2006); 8(Suppl. 4): 17-29.
13. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Sasaki S, Noma K, Hara K, Matsuura H, Goto C, Oshima T, Chayama K. Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition. J Cardivasc Pharmacol (2002); 35: 668-676.
14. Ignarro LJ. Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker. Blood (2004); 1(Suppl.): 2-16.
15. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Diab Rep (2005); 5: 17-23.
16. Kato Y, Kijima Y, Kitakaze M. Roles of systemic nitric oxide metabolites for human coronary circulation. Cardiovasc Drugs Ther (2004); 18: 189-195.
17. Kearney PM, Whelton M, Reynolds K. Global burden of hypertension: analysis of worldwide data. Lancet (2005); 365: 217-223.
18. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta (1999); 1411: 273-289.
19. Kelm V, Rath J. Endothelial dysfunction in human coronary circulation: relevance of the L-arginine-NO pathway. Basic Res Cardiol (2001); 96: 107-127.
20. Kosaka H. Nitric oxide and hemoglobin interactions in the vasculature. Biochim Biophys Acta (1999); 1411: 370-377.
21. Kourembanas S, Morita T, Christou H. Hypoxic reponses of vascular cells. Chest (1998); 114: 25S-28S.
22. Landmesser U, Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol (2005); 20: 547-551.
23. Landmesser U, Drexler H. Endothelial function and hypertension. Curr Opin Cardio (2007); 22: 316-320.
24. Luscher T., Barton M. Biology of the endothelium. Clin Cardiol (1997); 20(Suppl. II): 3-10.
25. Mehta J. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J (1995); 129: 382-391.
26. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991); 43: 109-142.
27. Moshage H, Kok B, Huzenga J, Jansen P. Nitrite and nitrate determination in plasma: A critical evaluation. Clin Chem (1995); 41: 892-896.
28. Paranti A, Filippi S, Amerini S. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivololl. J Pharm and Exp Therapeutics (2000); 292: 698-703.
29. Scheid P, Meyer M. Mixing technique for study of oxygen-hemoglobin equilibrium: A critical evaluation. J Appl Physiol (1978); 45: 818-822.
30. Shaul PW, Wells LB, Horning KM. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J Cardiovasc Pharmacol (1993); 22: 819-827.
31. Shaul PW, North AJ, Brannon TS. Pronged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mil Biol (1995); 13: 167-174.
32. Spieker LE, Flammer AJ, Luscher TF. The vascular endothelium in hypertension. Handb Exp Pharmacol (2006); 176: 249-283.
33. Stepuro TL, Zinchuk VV. Nitric oxide effect on the hemoglobin-oxygen affinity. J Physiol Pharmacol (2006); 57: 29-38.
34. Tzemos N, Lim PO, Macdonald TM. Nebivolol reverses endothelial dusfunction in essential hypertension: A randomized, double-blind, crossover study. Circulation (2001); 104: 511-514.
35. Ugrekhelidze J, Simonia G, Andronikashvili I, Kutateladze M. Influence of nebivolol on endothelial dysfunction in salt-sensitive hypertension. Georgian Med News (2006); 133: 56-58.
36. Wang J, Brown MA, Tam SH, Chan MC, Whitworth JA. Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol (1997); 24: 418-420.
37. Zinchuk V, Dorokhina L. Blood oxygen transport in rats under hypotermia combined with modification of the L-arginine-NO pathway. Nitric oxide (2002); 6: 29-34.
38. Zinchuk VV, Zinchuk NV. Effect of nebivolol on the blood oxygen transport. Eksp Klin Farmakol (2007); 70: 44-47.
39. Zinchuk VV, Pronko TP, Lis MA. Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension. Clin Physiol Funct Imaging (2004); 24: 205-211.